US Patent Issued to NYRADA on Sept. 29 for "Compounds for treatment of excitotoxicity" (Australian Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,238, issued on Sept. 29, was assigned to NYRADA PTY LTD (Sydney).

"Compounds for treatment of excitotoxicity" was invented by Phillip Coghlan (Sydney), Benny Evison (Sydney) and Jasneet Parmar (Sydney).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to modulators of canonical-type of transient receptor potential (TRPC) channels, compositions thereof, and methods therewith. The present invention also relates to methods of treating TRPC mediated conditions using such modulators."

The patent was filed on Jan. 27, 2026, under Application No. 19/460,795.

*For further information, including images, charts and tables, please ...